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of these two versions is not known. The purpose of this study
was to test the differential item functioning (DIF) between the
English and Chinese versions of the PDQ-8. METHODS: Data
collected using the English (N = 173) and Chinese (N = 117) ver-
sions of the PDQ-8 from patients with Parkinson’s disease in Sin-
gapore were analyzed. DIF was detected using both an ordinal
logistic regression model and a generalized partial credit model.
RESULTS: No DIF was detected for any of the 8 items of the
PDQ-8 between the English and Chinese versions. The only item
with suspicious DIF was “Due to having Parkinson’s disease,
how often during the last month have you felt unable to com-
municate with people properly?” Chinese-speaking patients
responded more positively than English-speaking patients to this
question; however, this difference was insigniﬁcant, either statis-
tically or according to pre-deﬁned effect size of minimal impor-
tance. CONCLUSION: The English and Chinese versions of the
PDQ-8 appear equivalent in measurement, thus data colleted by
these two versions can be pooled for data analysis without sta-
tistical adjustment.
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OBJECTIVES: To compare psychometric properties of selected
obstructive sleep apnea (OSA) speciﬁc health related quality of
life (HRQoL) instruments based on McHorney and Tarlov’s
(1995) criteria for individual decision making. METHODS: Four
instruments were identiﬁed using the following criteria: peer
reviewed publications using the instruments, focus of the instru-
ment on HRQoL, adequate psychometric data to evaluate the
instrument, instrument availability, and published in the English
language. The instruments were evaluated based on the follow-
ing criteria: item information, administration time, depth (ﬂoor
and ceiling effect), breadth, reliability (internal consistency and
test-retest), and validity. RESULTS: Of the four instruments eval-
uated: Functional Outcomes of Sleep Questionnaire (FOSQ);
Calgary Sleep Apnea Quality of Life Index (SAQLI); OSA
Patient-Oriented Severity Index (OSAPOSI); and Quebec Sleep
Questionnaire (QSQ); the FOSQ and SAQLI were most fre-
quently published and the QSQ and OSAPOSI were the least.
All instruments met study criteria for item information and
administration time. Only the SAQLI include physical, social and
mental HRQoL dimensions. Depth data was missing for the
majority of scales. The FOSQ and OSAPOSI met study criteria
for internal consistency (α > 0.90) for the total scores only. The
SAQLI met study criteria for internal consistency (α = 0.90 to
0.95 for daily activities, social and mental HRQoL dimensions)
and test-retest reliability (r > 0.90 all scales). While for the
remaining instruments, only the total score met study test-retest
reliability criteria. The FOSQ, SAQLI, and QSQ scales demon-
strated construct validity (convergent, discriminant and known-
groups) while OSAPOSI was supported by known groups only.
CONCLUSION: Our study results show that none of the instru-
ments met all the study criteria for individual decision making.
Available psychometric data support the use of SAQLI for indi-
vidual decision making.
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OBJECTIVES: The purpose of this study was to describe the
impact of RLS on overall health status, sleep, psychological 
functioning, work productivity, and other daily activities.
METHODS: A Web-based survey was presented to a multimil-
lion member panel of US adults. To be eligible, participants had
to be at least 18 years of age and currently experiencing RLS
symptoms as determined using established diagnostic criteria. In
addition to gathering information related to diagnosis, treat-
ment, and symptom frequency and severity, validated instru-
ments were administered to assess overall health (SF-12v2), sleep
(MOS Sleep), psychological distress (CES-D), and work produc-
tivity/activity limitations (WPAI and WLQ). Where possible,
scores for these instruments were compared to published norms.
A series of ANCOVA models were developed to evaluate the
relationship between symptom severity, diagnosis status, age 
and gender, and the impact of RLS. RESULTS: Participants
included 702 adults with RLS (396 diagnosed and 306 never
diagnosed). Means for the SF-12v2 scores (PCS = 35.6, MCS =
42.6) were at least 1 standard deviation lower than gender- and
age-adjusted general population norms. Participants reported
poorer sleep quality scores across each MOS Sleep domain, with
differences from published norms of more than 16 points on
100-point scales, as well as approximately one hour less sleep
per night on average. A majority (64%) of the RLS sample met
the cut-off score for depression on the CES-D. Compared to pop-
ulation norms, the RLS sample reported greater limitations 
in time management, physical demands, mental/interpersonal
demands, general work output, and usual activities. Symptom
intensity and frequency were shown to be the primary predictors
of RLS impact on the various outcomes. CONCLUSION:
RLS has a substantial impact on various aspects of patients’ 
lives including HRQOL, sleep, psychological distress, and work
productivity.
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OBJECTIVES: To compare comorbid conditions and economic
and humanistic factors between migraine sufferers and non-suf-
ferers using data from the 2005 U.S. National Health and Well-
ness Survey (NHWS). METHODS: Cases were deﬁned as those
respondents reporting physician diagnosis of migraine. Propen-
sity score matching methods were used to identify an identical
number of respondents not experiencing migraine (controls)
from the NHWS population matched for age, gender, and race.
Cases and controls were compared for rates of comorbid condi-
tions and lifestyle factors, economic parameters such as resource
utilization and work productivity (WPAI), and quality of life (SF-
8). Statistical analyses included chi-square tests and t-tests.
RESULTS: Of the 39,141 NHWS respondents, 4337 (11.1%)
reported a physician diagnosis of migraine and were matched to
4337 controls. Approximately 79.6% of cases and controls were
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female, 88.0% were white, and the mean age was 42 (SD = 12.5).
Migraine sufferers reported higher rates of lifetime cases of
arthritis (32.7% vs. 20.6%; p < 0.001) and gastroesophageal
reﬂux disease (23.3% vs. 11.9%; p < 0.001), and higher rates of
depression in the past year (43.7% vs. 25.7%; p < 0.001) than
their matched controls, as well as higher rates of hypercholes-
terolemia and hypertension (both p < 0.001). Migraine sufferers
had higher rates of emergency rooms visits (22.8% vs. 12.9%;
p < 0.001) and hospitalizations (11.9% vs. 7.5%; p < 0.001) in
the past six months, reported lower scores on both physical (44.8
vs. 49.2; p < 0.001) and mental (44.5 vs. 48.3; p < 0.001) com-
ponents of the SF-8, and had greater overall work impairment
due to health (20.6% vs. 12.1%; p < 0.001) than their non-
migraine counterparts. CONCLUSION: Migraineurs have
higher proportions of comorbid conditions, use more health care
resources, miss more time from work, and experience worse
health-related quality of life than non-migraine sufferers. These
results highlight the importance of providing adequate care for
these patients, to treat not only migraines, but also comorbid
conditions.
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OBJECTIVES: To measure the impact of chronic insomnia on
productivity, comparing good sleepers (GS) to chronic insomni-
acs (CI) in three countries. METHODS: A questionnaire mea-
suring various aspects of chronic insomnia was developed and
tested. Sample selection through on-line panels in the US and
France, an off-line panel in Japan, aimed to obtain a minimum
of 400 GS and 800 CI per country. Questions on time lost from
work (past month) measured the effect on productivity. Likert
scales (0–10) assessed effects on concentration, productivity at
work and daily life. CI were identiﬁed using the Insomnia Sever-
ity Index (ISI)1 and an insomnia history of >6 months. Non-
treated CI with an ISI-score between 8–14, co-morbid
insomniacs were excluded. RESULTS: For the US and France
478 and 998 GS and 820 and 860 CI were included respectively,
and 506 GS and 405 CI for Japan. 387, 243, and 202 CI were
treated in US, France and Japan respectively. CI miss signiﬁcantly
(p < 0.001) more hours and days of work than GS in the US 
and France. This was not observed in Japan. Signiﬁcant better
concentration (p < 0.01;0.01;0.005), productivity at work 
(p = 0.04;<0.0001;0.0005) and effects on daily life (p <
0.003;<0.0001;0.005) were found for treated CI compared to
non-treated CI in the US, France and Japan respectively. Differ-
ences were signiﬁcant (p < 0.001) when comparing GS to CI in
all countries. CONCLUSION: Discussion: The small sample and
missing data (hours/days worked) may have affected Japanese
results. CI in all countries showed similar patterns on the Likert
scales. Treated CI patterns approached GS patterns while con-
tinuing to show effects of chronic insomnia. CONCLUSION:
Chronic insomnia is associated with losses in days and hours
worked, reduced concentration productivity at work, a negative
effect on daily life. Treated CI show signiﬁcantly less impact of
chronic insomnia on concentration, productivity at work and
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OBJECTIVES: The aim of this retrospective study is to evaluate
the connection between 5 years mortality of patients with
femoral neck fracture and its different risk factors. METHODS:
The data derive from the ﬁnancial database of the Hungarian
National Health Insurance Fund Administration, based on the
10th revision of the International Classiﬁcation of Diseases
(ICD) with ICD code S7200. Patients over 60 years being dis-
charged in 2000 after primary treatment of femoral neck frac-
ture were included into the study. Patients with polytrauma were
not included into the study. We evaluated data according to sex,
age, co-morbidities, type of fracture, type of operation, early
complications, progressivity level of care, day of operation, sur-
gical delay. Statistical analysis was performed by Cox logistic
regression method. RESULTS: A total of 3783 patients met selec-
tion criteria. During the postoperative 5 years 61.88 % of
patients died. We calculated the hazard ratios by multivariate
regression analysis according to risk factors [95 % conﬁdence
interval, CI] and (p value) are also given. Sex: (female/male)
0.848 [0.772; 0.931] (0.000). Age: (70–79/60–69 year) 1.187
[1.028; 1.369] (0.018); (80–89/60–69 year) 1.264 [1.094; 1.460]
(0.001); (90+/60–69 year) 1.724 [1.452; 2.048] (0). Co-morbid-
ity: (yes/no) 1.199 [1.007; 1.428] (0.041). Type of fracture:
(medial/lateral) 0.874 [0.773; 0.988] (0.032). Typy of operation:
(osteosynthesis/arthroplasty) 1.129 [0.981; 1.300] (0.088). Early
complication: (yes/no) 1.173 [0.892; 1.541] (0.252). Progressiv-
ity level of care: (county/Budapest) 0.948 [0.844; 1.064] (0.368);
(national and university/Budapest) 0.787 [0.677; 0.914] (0.001);
(city/Budapest) 0.906 [0.807; 1.017] (0.096). Day of surgery:
(weekend/weekday) 1.049 [0.949; 1.159] (0.348). Surgical delay:
(6–12 h/0–6 h) 1.026 [0.901; 1.168] (0.691); (12–24 h/0–6 h)
1.12 [0.984; 1.274] (0.085); (24–48 h/0–6 h) 1.232 [1.052;
1.442] (0.009); (48+h/0–6 h) 1.139 [1.013; 1.281] (0.028).
CONCLUSION: Our ﬁndings conﬁrmed the signiﬁcant effect of
female gender, higher age-groups, co-morbidities, lateral type
fracture, lower progressivity level of care and surgical delay on
5 years mortality.
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OBJECTIVES: The purpose of this study was to analyze the 5-
year survival rate after medial femoral neck fracture according
to type of fracture (displaced or non-displaced) over 60.
METHODS: Data derive from the ﬁnancial database of the Hun-
garian National Health Insurance Fund Administration, based
on the 10th revision of the International Classiﬁcation of Dis-
eases (ICD) with ICD code S7200 and on the Hungarian Diag-
nosis Related Group (DRG) system. The following patients were
included into the study: having social insurance identiﬁcation
number, being discharged in 2000 after primary treatment of
femoral neck fracture. The patients with polytrauma were
